Summit Therapeutics Inc

SMMTNASDAQ · USD
16.91USD+0.52 (+3.18%)
125

Summit Therapeutics Inc (SMMT) Covered Calls

As of September 29, 2026, SMMT has 129 covered call opportunities in the coming three months. Return ranges from 3.7 to 207.2% until expiration. Annualized return ranges from 20.9 to 1,603.4%. The nearest expiration is October 2, 2026. Maximum potential profit is $3,396.

Read more

Running SMMT covered calls helps you generate consistent income from Summit Therapeutics Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Summit Therapeutics Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best SMMT covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if SMMT stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling SMMT covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Summit Therapeutics Inc covered call is worth writing.

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae.

The company was founded in 2003 and is based in Cambridge, Massachusetts.

Income-focused investors, long-term SMMT holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling SMMT covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Summit Therapeutics Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile53.97% Neutral
  • Market cap (M$)13,075
  • 52 weeks high-43.93%
  • 52 weeks low35.79%
  • Analyst recommendationBuy
    1.67
  • Target price$29.78
    71.85% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-10-19
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.12
  • EPS growth next 5 years23.53%

As of September 29, 2026

2026-10-02318.5012.870.050.15216.0013.181603.42-0.31+0.13860.10
2026-10-02318.009.820.150.20176.0010.741306.49-0.92+0.206640.05
2026-10-02317.506.770.200.30131.007.99972.44-1.22+0.275030.10
2026-10-091020.0022.030.100.20371.0022.64826.21-0.61+0.12220.10
2026-10-161722.0034.230.100.25571.0034.84748.00-0.61+0.111740.15
2026-10-091019.5018.970.100.40321.0019.59714.86-0.61+0.1810.30
2027-01-1510850.00205.060.350.703396.00207.20700.26-2.14+0.123,2430.35
2026-10-02317.003.720.300.4091.005.55675.51-1.83+0.368530.10
2027-01-1510847.00186.760.252.653086.00188.29636.34-1.53+0.241,0822.40
2026-10-161721.0028.130.150.40476.0029.04623.55-0.92+0.161710.25

As of September 29, 2026

Sell covered calls with the data behind you

Find the best SMMT covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial